Attacking tumor cells with a dual ligand for innate immune receptors. Editorial Article uri icon

Overview

publication date

  • April 1, 2012

Research

keywords

  • Cancer Vaccines
  • Neoplasms
  • Nod Signaling Adaptor Proteins
  • T-Lymphocytes
  • Toll-Like Receptors

Identity

PubMed Central ID

  • PMC3380570

Scopus Document Identifier

  • 84867182284

Digital Object Identifier (DOI)

  • 10.18632/oncotarget.484

PubMed ID

  • 22622007

Additional Document Info

volume

  • 3

issue

  • 4